Hopeful Advances — Umbilical‑Cord Mesenchymal Stem Cells for Type 2 Diabetes

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Diabetes research Diabetes research Type 2 diabetes and umbilical cord stem cells: the real evidence What randomized trials of umbilical cord stem cells in type 2 diabetes found for HbA1c and insulin, and what it means for you. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version In a placebo-controlled trial, cord stem cells lowered HbA1c and insulin needs more than placebo. The cells seem to work on the inflammation that makes tissue deaf to insulin, not on new beta cells. Every body responds at its own pace, and your own doctor keeps leading your diabetes care. You know the routine by heart. The finger prick, the pill organizer, the appointment where the HbA1c comes back a little higher and the dose goes up again. You are doing the work, and the numbers still drift. Umbilical cord mesenchymal stem cells are one of the most studied new ideas in type 2 diabetes. There is real, published human data now, including trials with a placebo group. Here is what those studies found, in plain words. Why does the sugar keep climbing? In type 2 diabetes the pancreas usually still makes insulin. The problem is that muscles, liver and fat stop responding to it well. That is insulin resistance, and a low, constant inflammation keeps feeding it. Imagine insulin as a key that still fits the lock, but the lock is gummed up. The pancreas answers by making more keys, and over years it gets tired. Medication helps you push the door open; it does not clean the lock. That is why researchers got interested in mesenchymal stem cells. They are known for their immunomodulatory effect: they release signals that may turn down chronic inflammation. The idea is not to replace your pancreas, but to take some weight off it. In plain wordsImmunomodulatory able to calm an overactive immune response without switching it off What did the trials actually find? The strongest single study is a double-blind, placebo-controlled phase II trial published in 2022. Ninety-one adults with type 2 diabetes received three intravenous infusions of umbilical cord MSCs or a placebo, four weeks apart, and were followed for 48 weeks. HbA1c, your three-month blood sugar average, fell by 1.31 points with the cells, versus 0.63 with placebo Insulin doses dropped more in the cell group About one in five treated patients reached the combined goal of HbA1c under 7% while halving their insulin, versus fewer than one in twenty on placebo No major treatment-related adverse events were reported A second trial from the same team, using continuous glucose monitors, found more time in range in the cell group at 9 and 48 weeks: steadier days, fewer highs. 17 systematic reviews pooled in a 2025 umbrella review of stem cells for diabetes How big is the bigger picture? A 2025 umbrella review pooled 17 systematic reviews and meta-analyses covering more than 8,000 patients. Across them, MSC therapy lowered HbA1c by up to about 1.45 points and reduced insulin needs, with the clearest effect in type 2. Side effects were mostly mild. The same review found that Wharton’s jelly MSCs, from the tissue of the umbilical cord, performed better than MSCs from umbilical cord blood. Same cord, different tissue, different results. MythStem cells grow you a new pancreas. Reality: The aim is to calm inflammation and help your body respond to insulin. In these studies, the measured gains came with less inflammation and better insulin response. How should you read these results? These trials are encouraging, and research is growing. Every body responds at its own pace, which is why your markers are measured before and after. Diet, movement and your usual medication still matter. The cells are studied as a partner to good diabetes care. What this means for you Bring your last HbA1c, glucose and insulin numbers; they are the starting line for your plan. Expect gradual change measured in lab results, and keep your doctor at home in charge of your medication. Send your numbers on WhatsApp for a free evaluation, with your plan and price in writing and no commitment. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care Several randomized trials and a large umbrella review suggest that mesenchymal stem cells may lower HbA1c and insulin needs in type 2 diabetes, with a reassuring safety record. Research is growing, and longer studies keep building on these results. Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial · Stem Cell Research & Therapy, 2022 Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes Assessed by Retrospective Continuous Glucose Monitoring · Stem Cells Translational Medicine, 2023 Mesenchymal stem cell therapy for diabetes: An umbrella review · Tissue and Cell, 2025 Bring your case How the doctors do it in Medellín The diabetes protocol uses Wharton’s jelly mesenchymal stem cells delivered intravenously over three days; exosomes can be added to your plan. It starts with blood work and cancer markers, then premedication and a detox IV. A functional-medicine doctor reviews your markers before you travel and follows the same numbers afterward, so the answer is a
Type 1 Diabetes and Regenerative Medicine: The Immunomodulatory Role of Umbilical Cord–Derived Mesenchymal Stem Cells

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Type 1 diabetes Type 1 diabetes Type 1 diabetes and stem cells: what they may do for you Type 1 diabetes is an immune problem first. How umbilical cord stem cells are studied to calm that attack, what trials found, and what it means for you. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version In type 1 diabetes the immune system attacks the cells in the pancreas that make insulin. Stem cells are studied to calm that attack and protect the insulin-making function still left. Trials show better C-peptide and HbA1c, working alongside your insulin. If you live with type 1 diabetes, you already run a small laboratory in your pocket: a sensor, a pump or a pen, and a brain that does carb math before breakfast. The technology has improved enormously, and research now looks at the root of the problem. That problem is the immune system. This post explains what goes wrong in type 1 diabetes, how umbilical cord mesenchymal stem cells are studied to work on it, what the trials actually found, and what that means for you. What is really going wrong in type 1? Type 1 diabetes is an autoimmune disease. For reasons that mix genes and environment, the immune system starts treating the beta cells of the pancreas, the ones that make insulin, as intruders. Immune cells called T cells lead the attack, and over time fewer and fewer beta cells are left. That is different from type 2 diabetes, where the body still makes insulin but the tissues respond to it poorly. In type 1 the issue is supply, and insulin from outside becomes essential. In plain wordsBeta cells the cells in the pancreas that make insulin, the ones the immune system attacks in type 1. What do today’s treatments leave untouched? Pumps, sensors and newer insulins make daily control safer and easier. But they replace the missing hormone; they do not change the immune attack itself. Many people still have some working beta cells, especially in the first years after diagnosis, and protecting what is left is a real goal. In plain wordsC-peptide a marker released with your own insulin. It shows how much insulin your body still makes. How could stem cells help with an immune problem? Think of the immune system in type 1 as a neighborhood watch that has started chasing the mail carrier. Mesenchymal stem cells don’t fire the watch; they are studied for calming it down. They release signals that may: Slow down the overactive T cells Encourage regulatory T cells, the immune system’s peacekeepers Lower inflammatory messengers around the pancreas Help protect the beta cells that are still working Stem Cells Colombia uses only mesenchymal stem cells from Wharton’s jelly, the soft tissue of the umbilical cord. Reviews describe umbilical cord cells as more primitive and more strongly immunomodulatory than adult sources. MythStem cells turn into new insulin-producing cells. Reality: Mesenchymal cells work on the immune system and inflammation, helping protect the beta cells you still have. What have trials found in people? A randomized trial in China gave Wharton’s jelly cells to 29 people with newly diagnosed type 1 diabetes, alongside intensive insulin therapy. Over two years, HbA1c and C-peptide were better in the treated group than with placebo, with no reported side effects. A 2025 umbrella review, pooling 17 systematic reviews and more than 8,000 patients with diabetes, found that in type 1 the therapy improved C-peptide and HbA1c. The safety profile was generally mild. 29 people in the randomized Wharton’s jelly trial in new-onset type 1 So what is the goal? The aim is to protect the function you still have and make your control steadier, alongside your insulin. Results are usually better when some beta cell function remains, which is often the case earlier after diagnosis. And one rule matters more than any other: never change or stop your insulin on your own, and never because of something you read online, including this post. Insulin is essential in type 1, so every change in dose is your doctor’s decision, for your safety. What this means for you Ask your doctor for a recent C-peptide test; it tells you how much of your own insulin remains. Think of this as protecting the insulin your body still makes, alongside your treatment. Keep your endocrinologist in charge of your insulin, before and after any treatment. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care Human evidence for mesenchymal stem cells in type 1 diabetes comes from randomized trials and pooled reviews. The most rigorous data show better C-peptide and HbA1c, most clearly in recent-onset disease, with a mild safety profile. The disease itself is well described as an immune attack, which is exactly what these cells are studied to calm. Research is growing, and larger, longer trials are building on these results. Long term effects of the implantation of Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus · Endocrine Journal, 2013 Mesenchymal stem cell therapy for diabetes: An umbrella review · Tissue & Cell, 2025 Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? · Tissue
Systemic Rheumatoid Arthritis and Regenerative Medicine: The Immunomodulatory Potential of Umbilical Cord–Derived Mesenchymal Stem Cells

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Autoimmune science Autoimmune science Rheumatoid arthritis is more than your joints. Can stem cells help? Why rheumatoid arthritis affects the whole body, how umbilical cord stem cells may help rebalance the immune system, and what trials show so far. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version Rheumatoid arthritis is an immune system problem that can reach the heart, lungs, eyes and skin. Umbilical cord stem cells are studied to rebalance that immune response rather than switch it off. Trials using the cells alongside standard drugs have shown lower inflammation markers and better disease scores. If you live with rheumatoid arthritis, you know it is not just a joint problem. It shapes your mornings, your energy and your plans, and you want more good days. Here is what drives it, where today’s medicines leave room for more, and what umbilical cord stem cells are being studied for. Why is rheumatoid arthritis a whole-body disease? In rheumatoid arthritis the immune system mistakes the lining of your joints for an enemy. Immune cells move in, release inflammatory messengers such as TNF and IL-6, and the lining thickens and starts eating into cartilage and bone. Those messengers don’t stay in the joints. They circulate in the blood, which is why rheumatoid arthritis can also affect the heart and blood vessels, the lungs, the eyes and the skin, and why it drains your energy. It is a bit like a neighborhood argument that spills into the whole street. In plain wordsAutoimmune when the immune system attacks the body’s own tissues by mistake. Where do umbilical cord cells fit next to your medicines? Methotrexate, biologics and steroids have changed life for a great many people with rheumatoid arthritis. They work by turning down immune activity, and for many that is enough to keep the disease quiet. For people who want more control of their disease, researchers are studying ways to calm the attack while leaving the rest of the immune system free to do its job. That is where umbilical cord cells come in. Tip Never stop or change your rheumatoid arthritis medication on your own. Any change is a decision for your rheumatologist. What do stem cells do to the immune system? Mesenchymal stem cells are natural peacekeepers. In lab studies with cells from patients with rheumatoid arthritis, umbilical cord cells calmed overactive joint-lining cells and T cells and helped expand regulatory T cells, the immune system’s own brakes. In mice with arthritis, infusing the cells lowered inflammatory messengers and eased the disease. The key word is modulate. The aim is not to switch the immune system off but to help it find its balance again, turning down the part that is attacking you. Think of a mediator at a noisy meeting: nobody gets thrown out, but everyone lowers their voice. In plain wordsRegulatory T cells immune cells whose job is to calm other immune cells and keep friendly fire in check. What have trials in people found? In a Chinese phase I/II study, 64 people with rheumatoid arthritis received umbilical cord stem cells through a vein while continuing their usual medicines. At one and three years, blood markers of inflammation had fallen, disease activity and daily-function scores had improved, and routine safety tests stayed normal. A 2024 meta-analysis of randomized trials in several kinds of arthritis also points to a potential benefit in rheumatoid arthritis, with a good safety record. Research is growing, and larger controlled trials are building on these results. MythStem cells replace your arthritis medication. Reality: In the trials, cells were added to standard treatment. Your rheumatologist decides whether anything changes. What this means for you Keep your rheumatologist and your medication at the center of your care. If you want more control of your disease, ask for an evaluation of stem cells as an add-on. Bring recent labs, including inflammation markers, to any consultation; they show where you are starting from. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care The immune-calming effects of umbilical cord stem cells are well documented in the lab and in animal models of arthritis. In people, early-phase trials, mostly from China and used alongside standard drugs, report lower inflammation markers and better disease scores with a good safety record. A meta-analysis of randomized trials points the same way. Research is growing, and umbilical cord cells are a promising add-on to your care. The pathogenesis of rheumatoid arthritis · The New England Journal of Medicine, 2011 Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis · Arthritis Research & Therapy, 2010 Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study · Drug Design, Development and Therapy, 2019 Efficacy and safety of culture-expanded mesenchymal stromal cell therapy in the treatment of 4 types of inflammatory arthritis: A systematic review and meta-analysis of 36 randomized controlled trials · Seminars in Arthritis and Rheumatism, 2024 Bring your case How the doctors do it in Medellín Your protocol is led by a rheumatologist, Dr. Andrés Martínez, who reviews your diagnosis and recent labs with you by video and designs your plan with you before you
The Role of Umbilical Cord–Derived Mesenchymal Stem Cells in Ligament Injuries

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Ligaments Ligaments Why ligaments heal slowly, and where stem cells may help Ligaments have a poor blood supply and tend to heal with scar. What umbilical cord stem cells are studied for in sprains and partial tears. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version Ligaments have little blood flow, so they often heal slowly and with weaker scar tissue. Stem cells are studied for calming inflammation and supporting better-organized repair. Studies have shown stronger, better-healed grafts, and the first human studies show promising safety. A sprained ankle that “never felt the same.” A knee that gives way on stairs. A partial tear that was supposed to settle in six weeks and is now celebrating its first birthday. Ligament injuries have a way of overstaying their welcome. There is a biological reason for that, and it is also why regenerative medicine has taken an interest in ligaments. Here is what happens when a ligament is injured, what stem cells are studied for, and what the evidence shows today. Why are ligaments so slow to heal? Ligaments are the strong bands that tie bone to bone and keep a joint stable. They are made mostly of collagen fibers, lined up like the strands of a rope, with relatively few cells and a poor blood supply. Less blood means fewer nutrients and fewer repair cells arriving at the injury. Healing is slow, and it often ends in scar tissue: collagen laid down in a messier pattern, like a rope repaired with a knot. It holds, but it can be weaker and more prone to another injury. That is also why the second sprain in the same ankle so often arrives with less warning than the first. In plain wordsCollagen type I the main structural protein of ligaments, the fibers that give them strength. What do the usual treatments do? Rest, bracing and physical therapy protect the joint and rebuild the muscles around it. For complete tears, such as many ACL ruptures in active people, surgical reconstruction replaces the ligament with a graft. These approaches mainly restore mechanical stability. They don’t directly change the biology of the healing tissue, and that is the gap regenerative medicine is trying to fill. What might stem cells add? Mesenchymal stem cells are sometimes described as a “drugstore” that sets up shop at the injury. They mainly act by releasing signals, growth factors and small messengers, that may: Calm lingering inflammation around the injury Encourage the ligament’s own repair cells to work Support more organized collagen instead of disordered scar Support the growth of small blood vessels that feed the tissue Stem Cells Colombia uses only mesenchymal stem cells from Wharton’s jelly, the soft tissue of the umbilical cord. They come from a donated cord after a healthy birth, so nothing is harvested from your own body. In plain wordsParacrine effect the cells help mainly through the messages they release, not by turning into ligament themselves. Which injuries are studied the most? Two situations come up again and again: Partial tears, chronic sprains and loose ligaments, where surgery is not clearly needed. Here cells are placed in or around the ligament under ultrasound guidance, aiming to calm inflammation and support healing. Help for a surgical repair, such as an ACL reconstruction. In animal studies, adding stem cells improved how well the graft matured and how much load it could take before failing. For a completely ruptured ligament with an unstable joint, your specialist reviews whether surgery should come first, so your plan is designed for you. MythAn injection can reattach a fully torn ligament. Reality: The cells are studied for partial injuries and for supporting healing, including alongside surgery in a complete rupture. What does the evidence show in people? Animal studies are consistent and encouraging: in a 2026 review, adding stem cells made ACL grafts clearly stronger at the point of failure, and the first human studies showed promising early safety. Research is growing, and larger studies are the next step to measure how people feel and function. Your specialist looks at your imaging first and explains what you can expect for your injury, so your plan is designed for you. What this means for you For a new sprain, protect the joint and start physical therapy; many heal well that way. If a partial tear or chronic sprain keeps bothering you after months, send your MRI for a free evaluation. For a complete tear with an unstable joint, your specialist tells you whether surgery comes first and how cells can support your recovery. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care A 2026 systematic review of 14 animal and early human studies found that stem cells improved graft maturation and strength after ACL reconstruction in animals, with promising early safety signals in people; research is growing. The idea of cells as an injury-site “drugstore” comes from a widely cited 2011 paper on how these cells act. The MSC: an injury drugstore · Cell Stem Cell, 2011 The Effect of Stem Cell-Based Therapies on Tendon Graft Healing and Ligamentization after Anterior Cruciate Ligament Reconstruction: A Systematic Review · Current Stem Cell Research & Therapy, 2026 Bring your case
The Potential of Umbilical Cord–Derived Mesenchymal Stem Cells in Rheumatoid Arthritis of the Hand Joints

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Hands & immunity Hands & immunity Rheumatoid arthritis in the hands: can cord stem cells help? Why rheumatoid arthritis targets the small joints of the hands, how umbilical cord stem cells are studied for it, and what trials have found. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version Rheumatoid arthritis is an immune disease that often starts in the small joints of the hands. Umbilical cord stem cells are studied to rebalance the immune response and calm joint inflammation. Human trials show lower inflammation and disease activity for months, as an add-on to your medication. Your hands open jars, write notes, hold the people you love. You want them working with you again. If rheumatoid arthritis lives in your knuckles and wrists, you already know it is more than joint pain. It’s your grip, your handwriting, your independence. Let’s look at where umbilical cord stem cells fit. Why does rheumatoid arthritis love the hands? Rheumatoid arthritis, or RA, is an autoimmune disease: your immune system mistakes the lining of your joints, the synovium, for a threat. The small joints of the hands and wrists have a lot of that lining relative to their size, and they are often among the first joints involved. The inflamed lining thickens and releases chemicals such as TNF and IL-6. Over time, that inflammation can wear away cartilage and bone, which is why early, steady control matters so much. In plain wordsSynovium the thin lining inside a joint that makes its lubricating fluid. In RA, it becomes inflamed and swollen. If I already take medication, why look at anything else? Modern RA medicines, including methotrexate and biologics, have changed lives. For many people they are enough. For people who want more control of their disease on top of their medicines, stem cells have been studied as an add-on. What would the cells do? Mesenchymal stem cells, or MSCs, from umbilical cord tissue act on the immune system rather than on a single molecule. In studies, they raised the number of regulatory T cells, the immune system’s peacekeepers, and lowered inflammatory signals like TNF and IL-6. Picture an orchestra where the brass section has taken over. A biologic takes away one trumpet. MSCs are studied as something closer to a conductor, trying to bring the whole section back into balance. MythStem cells replace my RA medication. Reality: In the trials, cells were added to standard medication. Any change to your treatment is decided with your rheumatologist. What have human studies found? The largest study the specialists know of included 172 people with active RA whose medication was not enough. Those who received cord MSCs on top of their medication had lower TNF and IL-6, more regulatory T cells and lower disease activity scores, with a good safety record. The effect lasted about three to six months, and repeating the treatment strengthened it. A 2020 systematic review of in vivo studies, four clinical trials in patients with active rheumatoid arthritis, found the treatment safe and well tolerated, with improvements in symptoms and significant drops in inflammatory molecules such as CRP, TNF and IL-6. 3–6 months how long improvements lasted after one course in the largest cord MSC study in RA Systemic, local, or both? RA is a whole-body disease, so the studies above used intravenous infusions. When one or two hand joints stay swollen and painful despite good overall control, a targeted application into those joints, under ultrasound, is another option to discuss. Which route makes sense depends on how active your disease is overall, and your rheumatologist designs that plan with you. What should you bring to your first consultation? Your diagnosis and the name of your rheumatologist. Every medication you take or have tried, and why you stopped any of them. Recent blood work, especially inflammation markers. X-rays or ultrasound of your hands, if you have them. It sounds like paperwork, and it is. But it is the paperwork that lets a specialist give you a real answer instead of a polite guess. What this means for you Keep your rheumatologist and your medication; stem cells were studied as an add-on. Ask whether your disease is active overall or concentrated in a few hand joints. Every body responds at its own pace; in studies, improvement built over weeks and lasted three to six months, and repeating the treatment strengthened it. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care Several clinical studies, including a cohort of 172 patients treated with umbilical cord MSCs, have reported lower inflammatory markers and disease activity in active RA, with a good safety record. A 2020 systematic review of in vivo studies in patients confirmed the good safety record, with improvements in symptoms and lower inflammatory molecules. Most studies used intravenous delivery, and research on targeted hand-joint applications is growing. The pathogenesis of rheumatoid arthritis · New England Journal of Medicine, 2011 Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy · Stem Cells and Development, 2013 Therapeutic potential of mesenchymal stromal stem cells in rheumatoid arthritis: a systematic review of in vivo studies · Stem Cell Reviews and Reports, 2020 Bring your case Two ways
Vertebral Compression Fractures and how stem cells can help.

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Spine science Spine science Vertebral compression fractures: where stem cells might fit When a weakened vertebra collapses, the usual care focuses on pain and stability. What research on Wharton’s jelly stem cells adds. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version A compression fracture happens when a weakened vertebra partly collapses, often because of osteoporosis. Standard care is pain control, bracing, bone-building medication and sometimes cement procedures. A randomized trial added Wharton’s jelly stem cells to bone medication, with better pain, function and bone structure. Sometimes it happens with a fall. Sometimes it happens lifting a bag of groceries, or even with a sneeze, and a sharp pain in the middle of the back announces that a vertebra has given way. A vertebral compression fracture is painful, and it is also a message from your bones. Here is what it is, how it is usually treated, and what the research on stem cells has shown. What is a compression fracture? Each vertebra has a block-shaped body at the front that carries your weight. When the bone inside gets thin and porous, that block can crush down, usually at the front, into a wedge shape. Think of a sugar cube that has been left in a damp room. It still looks like a cube until you press on it. Osteoporosis is the most common cause, which is why these fractures are more common after menopause and later in life. One fracture also raises the chance of another, so the bones behind it deserve attention too. In plain wordsOsteoporosis a condition in which bones lose density and their inner structure thins, so they break more easily. When should you see a doctor right away? Sudden back pain after a fall, or new back pain after age 50 that doesn’t ease with rest, deserves an X-ray or MRI. So does any fracture that happened with little or no force: your doctor should find out why the bone was weak. Numbness, weakness in the legs, or trouble with bladder or bowels are emergencies. Those are reasons to go to a hospital today, not to read another article. Tip Ask whether your fracture is recent or old. An MRI can often tell, and it changes which treatments make sense. How is it usually treated? Pain control and a short period of reduced activity. A brace, in some cases, for comfort and support. Bone-building or bone-protecting medication to treat the osteoporosis behind the fracture. Vertebroplasty or kyphoplasty, procedures that inject bone cement into the collapsed vertebra, for selected cases. Most of these work on pain and stability, and the medication works on bone density over months. Stem cells are studied for something different: the healing environment inside the fractured bone. What could stem cells add? Mesenchymal stem cells, or MSCs, release signals that may calm inflammation, encourage new blood vessels and support the cells that build bone. In a fracture, that is the environment healing depends on. The idea being studied is not to replace standard care, but to add a biological push to it. For people whose bones are already fragile, it matters that the cells come from donated umbilical cords, so nothing is harvested from their own bones. MythStem cells can rebuild a collapsed vertebra to its original shape. Reality: The goal studied is better bone quality and less pain, alongside standard treatment. What does the research actually show? The most relevant study used exactly the kind of cells Stem Cells Colombia works with: Wharton’s jelly MSCs. In a randomized trial in Korea, people with recent osteoporotic compression fractures received either a standard bone-building medication, teriparatide, alone, or the same medication plus Wharton’s jelly MSCs placed in the bone and given by IV. Both groups improved in bone density. The group that also received cells reported greater improvements in pain, disability and quality of life, and CT scans at six and twelve months showed better bone microarchitecture. The treatment was well tolerated. Fourteen people completed follow-up. It is a promising first step, and research is growing. 14 patients who completed follow-up in the Wharton’s jelly trial for compression fractures What this means for you Make sure the cause of the fracture, usually osteoporosis, is being treated, not just the pain. Ask whether your fracture is recent, since that is where the research on cells has focused. Ask for a free evaluation of stem cells as an add-on to your treatment. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care A randomized phase I/IIa trial found that adding Wharton’s jelly MSCs to teriparatide was feasible and well tolerated in recent osteoporotic vertebral fractures, with greater gains in pain, function and bone microarchitecture than medication alone. The trial was open-label, and larger controlled studies are building on these results. Safety and efficacy of Wharton’s jelly-derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: a phase I/IIa study · Stem Cells Translational Medicine, 2021 The MSC: an injury drugstore · Cell Stem Cell, 2011 Bring your case Send your case The spine team, Dr. Diana Reyes, anesthesiologist and pain specialist, and Dr. Esteban Toro, interventional pain physician, works under fluoroscopic guidance in a fully equipped operating room. They are
Sacroiliac Joint Dysfunction and Regenerative Medicine

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Spine science Spine science Sacroiliac joint pain: the back pain that isn’t in your spine Pain low in the back, near the dimple of your hip, may come from the sacroiliac joint. What it is, how it is treated, and where stem cells fit. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version The sacroiliac joint links your spine to your pelvis, and it can cause pain that feels like back pain. It is often missed, because its pain overlaps with disc, hip and nerve problems. The doctors treat both SI joints with stem cells in one day, guided by fluoroscopy in the operating room. You point to the pain and it’s not quite your back and not quite your hip. It’s that spot just beside the dimple above your buttock, and it gets louder when you climb stairs, roll over in bed or stand on one leg to put on your pants. That spot may be your sacroiliac joint, or SI joint. It is one of the most overlooked sources of low back pain, partly because it is so good at impersonating everything around it. What is the sacroiliac joint, and why does it hurt? You have two SI joints, one on each side, where the base of your spine (the sacrum) meets your pelvis. They don’t move much, but they carry the full load between your upper body and your legs every time you walk. Think of them as the hinges on a heavy barn door. They barely swing, but if one gets worn, loose or inflamed, you feel it with every push. Common triggers include a fall, years of repetitive strain, pregnancy, a difference in leg length, arthritis, and a previous spinal fusion that shifts extra stress onto the pelvis. In plain wordsSacrum the triangular bone at the bottom of your spine, wedged between the two sides of your pelvis. Why is it so often missed? SI joint pain overlaps with pain from a disc, a facet joint, the hip, or a pinched nerve. There is no single scan that shows “this is the one.” Doctors usually combine a careful exam with specific movement tests. The most reliable confirmation is a diagnostic block: a little numbing medicine placed into the joint under imaging. If the pain fades for a few hours, the SI joint is the likely culprit. Tip Before any treatment, ask how your doctor confirmed the pain comes from the SI joint. It is the most useful question on this list. What are the usual treatments? Physical therapy to strengthen the muscles that stabilize the pelvis. Anti-inflammatory medication for flare-ups. Steroid injections into the joint, guided by imaging. Radiofrequency ablation, which quiets the small nerves that carry the pain signal. Fusion surgery, usually reserved for cases where nothing else has worked. The first four can help a lot, and when their effect fades, fusion is a permanent step. That gap is where people start asking about regenerative options. Where could stem cells fit? Mesenchymal stem cells, or MSCs, work mainly as messengers. Placed in and around an inflamed joint, they release signals that may calm inflammation and support the joint’s cartilage and ligaments. For the SI joint, that means placing cells into the joint, and sometimes into the ligaments around it, under imaging guidance. It is what the doctors do in Medellín, under fluoroscopy, the same way they treat the spine. The goal is to improve the joint’s environment, not to lock it in place. MythIf an injection didn’t work, nothing will. Reality: Sometimes the injection was fine and the target was wrong. Confirming the pain source comes first. What does the evidence say? The research is growing and promising. A 2025 systematic review of PRP and stem cell injections into the SI joint included two randomized trials and three observational studies, and described the emerging clinical evidence as promising. Another 2025 review of SI joint treatments, covering 38 clinical studies, describes fluoroscopy-guided injections as the way to deliver steroids or mesenchymal stem cells directly into the joint, and points to regenerative medicine as one of the new therapies to explore. Every body responds at its own pace, which is why your follow-up tracks your progress with you. What this means for you If your pain sits beside the dimple above your buttock, ask whether the SI joint has been checked. Ask for the pain source to be confirmed, ideally with a diagnostic block, before any treatment. Send your imaging on WhatsApp for a free evaluation of both SI joints, with your plan and price in writing and no commitment. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care The anatomy and mechanics of the SI joint are well described, and inflammation and ligament strain are recognized contributors to pain. Stem cell and PRP injections into the SI joint have been studied in randomized trials and observational studies, and a 2025 systematic review described the emerging evidence as promising. Research on MSCs in other joints supports the rationale, and larger SI-joint trials will help define who benefits most. The sacroiliac joint: an overview of its anatomy, function and potential clinical implications · Journal of Anatomy, 2012 A systematic review
Rotator Cuff Tears and Regenerative Medicine: The Therapeutic Potential of Umbilical Cord–Derived Mesenchymal Stem Cells

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Shoulder science Shoulder science Rotator cuff tears: where stem cells may help your shoulder Why rotator cuff tendons fray, how tears are classified, and what umbilical cord stem cells may offer, with the evidence in plain words. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version Most rotator cuff tears come from slow wear of the tendon, not one big accident. Partial and degenerative tears are often treated without surgery, and a specialist reviews your images first. Stem cells are studied to calm inflammation and support tendon repair; human studies have found them safe and potentially helpful. Reaching for the top shelf hurts. Putting on a jacket hurts. Sleeping on that side is out of the question, so you wake up every time you roll over. If this is your shoulder, there is a good chance the rotator cuff is involved. Here is what that group of tendons does, why it frays, and where stem cells might fit among the options. What is the rotator cuff? Four small muscles wrap around the ball of your shoulder like fingers holding an orange. Their tendons form a cuff that keeps the ball centered in its shallow socket while the big muscles do the lifting. The shoulder is the most mobile joint you have, and that freedom has a price: the cuff works hard all day, every day, and has little room to spare. The tendon on top, the supraspinatus, takes the most punishment. In plain wordsTendon the tough cord that attaches a muscle to a bone. Why do these tendons tear? Sometimes it is a fall or a heavy lift. Much more often, the tendon wears out over years, a bit like a rope that frays one fiber at a time before it finally splits. Blood supply to part of the tendon is poor, inflammation lingers, and the collagen fibers lose their neat, parallel order. Researchers studying tendons removed during surgery found that the tissue around a tear is also degenerated, not just the torn edges. In other words, a tear is usually the end of a long story in the whole tendon, not a single bad day. Tip Pain at night and pain when lifting your arm to the side are classic cuff signs. Mention both to your doctor. What kind of tear do you have? Tears come in two broad kinds: Partial-thickness tears: the tendon is frayed or partly torn but still attached. Very common, and usually treated without surgery. Full-thickness tears: the tendon is torn all the way through. Some of these, especially large ones in active people or after an injury, do better with surgical repair. Physical therapy is the first step for most shoulders. Cortisone can quiet the pain for a while, but repeated shots may weaken tendons. Surgery stitches the tendon back to the bone, followed by weeks in a sling and months of rehab. What could stem cells add? A frayed tendon needs a calmer environment and better repair signals. That is exactly what mesenchymal stem cells are studied for. Rather than turning into new tendon, they act like a mobile pharmacy, releasing molecules that calm inflammation, encourage new small blood vessels and help organize collagen. Stem Cells Colombia uses cells only from the Wharton’s jelly of donated umbilical cords. Cord cells are young and active, and because they are well tolerated they can come from a donor, so nothing is taken from your own bone marrow or fat. They are studied most in partial or degenerative tears, tendinopathy, or a shoulder that has stopped responding to injections. A specialist reviews your images first, so your plan is designed for your shoulder. MythAn injection works like stitches. Reality: The aim is to calm inflammation and support your body’s own repair, so a damaged tendon may heal better. What does the evidence say? Most of the evidence comes from lab and animal studies, where umbilical cord cells improved the quality of tendon healing. A 2023 systematic review of umbilical cord tissue and cells for rotator cuff injuries found them safe and potentially helpful, and research with larger randomized trials is growing. What this means for you Get an ultrasound or MRI that says whether your tear is partial or full-thickness. If it is partial or degenerative, ask about regenerative options before surgery. Send your images on WhatsApp for a free evaluation, with your plan and price in writing and no commitment. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care Evidence for umbilical cord stem cells in rotator cuff disease comes mostly from lab and animal work, plus human studies. A systematic review describes them as safe and potentially effective, and larger randomized trials are building on it. The idea that mesenchymal cells act mainly through the signals they release is well established in the scientific literature. Every body responds at its own pace, which is why your follow-up tracks your progress with you. Allogenic Umbilical Cord Tissue for Rotator Cuff Injuries · Sports Medicine and Arthroscopy Review, 2023 Histopathology of the supraspinatus tendon in rotator cuff tears · The American Journal of Sports Medicine, 2008 The MSC: an injury drugstore · Cell Stem Cell, 2011 Bring your case How
What Types of Stem Cells Exist?

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · Stem cells 101 Stem cells 101 What types of stem cells exist? A plain-English field guide Embryonic, adult, induced, cord blood, Wharton’s jelly, Muse. What each kind of stem cell is, where it comes from and how it is used today. 6 min readReviewed with the medical team of Stem Cells Colombia The 30-second version Stem cells differ in how many cell types they can become and where they come from. Embryonic and induced cells can become almost anything, which is also what makes them hard to control. Umbilical cord blood and cord tissue (Wharton’s jelly) are different sources with different uses. At a family dinner someone says “stem cells” and suddenly everyone is an expert. Your cousin read they come from embryos. Your uncle heard they come from fat. Your neighbor’s friend banked her baby’s cord blood. Here is the twist: they are all partly right, because there are several very different kinds. This is a field guide to the main types, what makes each one special, and where each one is actually used today. No lab coat required. What makes a cell a stem cell? Two talents. A stem cell can make copies of itself, and it can give rise to more specialized cells, like bone, cartilage or blood. How many different cell types it can become is called its potency. Think of a stem cell as a student who has not chosen a career yet. Some can still become anything; others have narrowed it down to a few fields. In plain wordsPluripotent able to become almost any cell type in the body Embryonic stem cells: the blank slate? These come from very early embryos, usually left over from in vitro fertilization. Scientists first grew human embryonic stem cell lines in 1998. They are pluripotent, which makes them a powerful research tool. Two questions follow them: the ethical debate about using embryos, and the tight control that cells able to become anything need to grow the right way. Their clinical use is limited to carefully regulated trials. Induced pluripotent cells: reprogrammed adults In 2006, Japanese researchers showed that ordinary adult cells, like skin cells, could be reprogrammed back into a pluripotent state with a handful of genes. These are iPSCs, and the discovery earned a Nobel Prize. They avoid the embryo question and can be made from your own cells. The catch: the reprogramming can leave genetic changes behind, and like embryonic cells, they need tight control. Today they are mostly used to study diseases and test drugs, with early clinical trials underway. Adult stem cells: the repair crew Your body keeps small reserves of stem cells in many tissues to maintain and repair them. They are more specialized: blood stem cells make blood, for example. They also tend to lose some vigor with age. One family matters most in regenerative medicine: mesenchymal stem cells (MSCs). They are found in bone marrow, fat and umbilical cord tissue, and they are defined by international lab criteria. Their main talent is not transforming, but releasing signals that calm inflammation and support repair. Where they come from changes how they behave, which is why the source is always worth asking about. In plain wordsMesenchymal stem cells support cells that mostly help by releasing signals that calm inflammation and aid repair Cord blood or cord tissue: what is the difference? They are often confused, and they should not be. Umbilical cord blood is rich in blood-forming stem cells and is used in transplants for certain blood disorders. That is what families bank at birth. Wharton’s jelly is the soft tissue inside the cord itself. It is a source of mesenchymal stem cells, collected from cords donated after healthy births, with no harm to mother or baby. Same cord, different tissue, different cells. MythUmbilical cord stem cells are all the same thing. Reality: Cord blood gives mostly blood-forming stem cells; cord tissue (Wharton’s jelly) gives mesenchymal stem cells. They are used for different purposes. And Muse cells? Muse cells, short for multilineage-differentiating stress-enduring cells, were described in 2010 by a team in Japan as a rare, stress-tolerant subgroup found within mesenchymal cell populations. In lab studies they could produce cells of all three germ layers without forming tumors in mice. They are an active research area, with early-stage clinical studies. Stem Cells Colombia does not offer Muse cells: the doctors decided there is not yet enough published research. The doctors prefer to work with the cells that have the deepest body of research: Wharton’s jelly mesenchymal cells. What this means for you When a clinic says “stem cells”, ask which type and from which tissue. Cord blood and cord tissue (Wharton’s jelly) are different sources with different uses. Be wary of anyone who claims one cell type is proven best for everything. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care The main types of stem cells and how to define them are well established in the scientific literature. How each type helps a specific condition is studied in clinical trials, condition by condition, and research is growing. Embryonic stem cell lines derived from human blastocysts · Science, 1998 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by
What Are Stem Cells?

Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Blog · The basics The basics What are stem cells? A plain-English guide Two superpowers, four main families, and one common mix-up about the umbilical cord. Everything you need to follow the stem cell conversation. 5 min readReviewed with the medical team of Stem Cells Colombia The 30-second version Stem cells can copy themselves and can become other, more specialized cells. The main families: embryonic, adult (tissue), reprogrammed (iPS), and umbilical cord cells. Cord blood and cord tissue are different sources. Wharton’s jelly is the tissue, not the blood. Every one of the trillions of cells in your body started from one. Somewhere along the way, cells decided to become skin, bone, blood or nerve, and some of them kept the option open. Those are stem cells. The term gets thrown around a lot, often by people selling something. So here is a calm, jargon-free tour: what makes a cell a stem cell, the main families, and where the cells used in regenerative medicine fit in. What makes a cell a stem cell? Two abilities. First, it can self-renew: divide and make more copies of itself. Second, it can differentiate: turn into more specialized cells, like muscle, bone or blood. Most of your cells gave up that second option long ago. A skin cell makes skin. A stem cell is still deciding. In plain wordsDifferentiation a cell choosing a career, going from general-purpose to a specific job What are embryonic stem cells? They come from embryos a few days old and can become almost any cell type in the body. Scientists call that pluripotent. That flexibility makes them valuable for research, but hard to control in patients, and their use raises ethical questions many people care about. They are not what regenerative clinics use. What are adult stem cells? They live in your tissues all your life, keeping things in repair. Blood-forming stem cells in your bone marrow make new blood cells every day. Others help maintain skin, gut and muscle. They are more limited, usually becoming cells related to their own tissue. Mesenchymal stem cells belong here: support cells found in bone marrow, fat and the umbilical cord that can form bone, cartilage and fat in the lab. In plain wordsMultipotent able to become several related cell types, but not every type What are iPS cells? In 2006, Japanese researchers showed that ordinary adult cells could be reprogrammed back into an embryo-like state by switching on a few genes. They called them induced pluripotent stem cells, or iPS cells. It earned a Nobel Prize and opened huge research doors, from studying diseases in a dish to testing drugs. Treatments with iPS cells are still at the research stage. Cord blood or cord tissue: what’s the difference? This is where many articles get muddled. Cord blood is the blood inside the umbilical cord and placenta, rich in blood-forming cells used in some hospital transplants. Cord tissue is the cord itself. Its soft, gel-like filling, called Wharton’s jelly, is rich in mesenchymal stem cells. Same cord, different cells, different uses. Wharton’s jelly cells are the ones Stem Cells Colombia uses. MythUmbilical cord stem cells are all the same thing. Reality: Cord blood mostly gives blood-forming cells. Wharton’s jelly, the cord tissue, gives mesenchymal cells. Are stem cells working in you right now? Yes, quietly. Your bone marrow makes new blood cells every day, and stem cells in your skin and gut keep those surfaces renewed. When you cut a finger, local stem and support cells help close the gap. With age, those repair systems slow down, a bit like a crew that shrinks year after year. Regenerative medicine studies whether adding outside cells, and their signals, can help the crew along. Why do mesenchymal cells matter for treatment? Beyond what they can become, mesenchymal cells release signals that calm inflammation and help tissues repair. That signaling is the main reason they are studied for joints, the spine and immune-related conditions. Cells from Wharton’s jelly come from very young tissue and grow well in the lab. For a patient, they also mean no procedure to collect cells from your own body. What this means for you When someone says “stem cells,” ask which kind and from which tissue. Know that cord blood and cord tissue are different sources. Look for clinics that explain their cells in plain words, without miracle talk. Where the evidence stands Lab & animal studiesFirst human studiesSeveral clinical trialsStandard of care The basic biology of stem cells is well established, and mesenchymal cells have an agreed definition set by the International Society for Cellular Therapy. Wharton’s jelly cells meet that definition and have been studied in many laboratory and animal models. Clinical use of mesenchymal cells is being tested in human trials, and research is growing across many conditions. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement · Cytotherapy, 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors · Cell, 2006 Wharton’s jelly-derived cells are a primitive stromal cell population · Stem Cells, 2008 Bring your case The cells Stem Cells Colombia uses, and why Stem Cells Colombia uses only mesenchymal stem cells from Wharton’s jelly, from umbilical cords
